The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging For millions of Americans suffering from ...
This strategic acquisition enhances Vygon’s leadership in vascular access and supports its ambition to accelerate growth in the United States, where extended-dwell catheters represent a significant ...
Through a unique combination of sample-locking architecture, passive media exchange, and imaging-grade optics, the VitroPrime™ 3D Culture and Imaging Plate addresses persistent challenges in 3D cell ...
In this ever-changing healthcare landscape, prioritizing data-driven decision-making and proactively adopting advanced technologies will position health systems to achieve lasting success in 2026 and ...
FDA Breakthrough-designated device under evaluation for treatment of life-threatening abdominal bleeding at leading U.S. trauma centers shows promising results in first patient Arsenal Medical, a ...
The Calibreye System is for investigational use only and is not for sale in the U.S. or outside the U.S. Myra Vision, a Shifamed portfolio company, today announced the first patient enrolled in its ...
16.3.25. Zenith Sales & Calibrations Pty Ltd.
The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in ...
Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, today announced FDA approval to initiate the SUPPORT II ...
Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development for Near-Term Value Creation, Addressing a $2 Billion Potential Target Market Medicus Pharma Ltd. (NASDAQ: MDCX) ...
Johnson & Johnson Boosts U.S. Presence with $1 Billion+ Investment in Next‑Gen Cell Therapy Facility
Facility will boost Pennsylvania’s economy by creating more than 4,000 construction jobs and 500 biomanufacturing jobs, while further strengthening the Company’s annual $10 billion economic impact ...
Today the market offers a growing variety of modern alternatives that blend therapeutic benefit with home-friendly design For people who need extended periods of rest or recuperation, the bed itself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results